Increased NKILA expression reduces κBα phosphorylation inhibitors (IκBα) and nf-κB activity involved in the development of hepatocellular carcinoma. It also inhibits migration, proliferation and induces apoptosis. This evidence concerns the gene NFKB1 and hepatocellular carcinoma.